Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nebulin is a giant cytoskeletal protein of approximately 600–900 kDa that forms an integral part of the skeletal muscle thin filament. Composed of a high number of repeating actin-binding domains, nebulin stabilizes actin filaments, specifies thin filament lengths, and organizes the contractile machinery of muscle cells. Its C-terminal SH3 domain is embedded in the sarcomere Z-disc, where it binds various partners, including α-actinin and titin, contributing to Z-disc structure and myofibril alignment. Mutations in the NEB gene cause nemaline myopathy (often designated as "nemaline myopathy type 2"), indicating the essential role of nebulin in muscle development and function. Beyond its structural roles, nebulin has been implicated in actin nucleation (with N-WASP) and calcium homeostasis in muscle fibers. Its function and expression are largely restricted to skeletal muscle, and it is not a recognized druggable or pharmacological target at this time.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nebulin (NEB).